Congenital Heart Disease Market Segmentation, Application, Technology & Market Analysis Research Report 2023
Global Congenital Heart Disease Industry
New Study On “2018-2023 Congenital Heart Disease Market Global Key Player, Demand, Growth, Opportunities And Analysis Forecast” Added To Wise Guy Reports Database
The market for congenital heart disease across the globe is expected to grow impressively during the forecast period. The factors driving the growth of the global congenital heart disease market are rising prevalence of congenital heart disease and rise in adoption of minimally invasive procedures. Further, large number of dominating market players, growing demand for catheterization and application of cardiac biomarkers in congenital heart disease treatment are also considered as a major factor for driving the growth of the global congenital heart disease market during forecast period. In addition, advances and research in congenital heart disease and significant research funding for various projects are creating enormous opportunities for the global congenital heart disease market in coming years. The diagnosis and treatment for congenital heart disease has been changed significantly during the last decade. New interventional cardiology procedure and improved surgical techniques results in using minimally invasive techniques for the treatment of congenital heart disease. Adoption of minimally invasive technique reduces the patient’s surgical offence and also reduced hospital stay time.
Try Sample Report @ https://www.wiseguyreports.com/sample-request/3271373-global-congenital-heart-disease-market-research-and-forecast-2018-2023
In the US, one of the leading cause of infant deaths is congenital heart disease and accounts for more than half of all deaths from congenital anomalies across the globe. During heart development, structural defects arises which causes congenital heart disease. Congenital heart disease is the most common type of birth defect, affecting around 8 per 1000 live births in the US, approximately 25% of whom will require invasive treatment within the first year of life. This increasing prevalence of congenital heart disease is expected to increase the demand for diagnosis and treatment across the globe.
The global congenital heart disease market is analysed on the basis of geographical regions that are contributing significantly to the growth of the market. North America is estimated to be the dominating region in the global congenital heart disease market. Increasing adoption of minimally invasive procedures and large number of market players in this region is estimated to be the major factors that are backing the growth of the market. Whereas, Asia Pacific is estimated to be the fastest growing region during the forecast period. Growing demand for catheterization and application of cardiac biomarkers for the treatment of congenital heart disease are some of the major factors that are driving the growth of the congenital heart disease market in the region.
Key players of congenital heart disease market include Abbott Diagnostics, Array Biopharma, Inc., AstraZeneca Plc, Becton and Dickson & Co., BG Medicine Inc., Bio-Rad Laboratories, Boston Scientific Corporation, Covance, Critical Diagnostics, F. Hoffmann-La Roche Ltd, Glaxosmithkline PLC, Janssen Pharmaceuticals, Inc., Medtronic, Merck & Co., Inc., and Mylan N.V. These market players are increasingly competing against each other by adopting different market strategies such as merger & acquisition, partnership & collaboration and so on.
Research Methodology:
The market study of global congenital heart disease market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.
Secondary sources include:
• Financial reports of companies involved in the market
• Whitepapers such as research-papers and news blogs
• Company websites and their product catalogue.
The Report is intended for Researchers in healthcare segment, medical sensor companies in the market, Investing companies, Government Organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, growth opportunity in market, product types. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation:
1. Global congenital heart disease market by defect type
2. Global congenital heart disease market by diagnosis
3. Global congenital heart disease market by treatment
4. Global congenital heart disease market by end user
THE REPORT COVERS:
• Comprehensive research methodology of global congenital heart disease market
• In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global congenital heart disease market
• Insights about market determinants which are stimulating the global congenital heart disease market
• Detailed and extensive market segments with regional distribution of forecasted revenues
• Extensive profiles and recent developments of market players
Companies Mentioned
- ABBOTT DIAGNOSTICS
2. ARRAY BIOPHARMA, INC.
3. ASTRAZENECA PLC
4. BECTON AND DICKSON & CO.
5. BG MEDICINE INC.
6. BIO-RAD LABORATORIES
7. BOSTON SCIENTIFIC CORPORATION
8. COVANCE
9. CRITICAL DIAGNOSTICS
10. F. HOFFMANN-LA ROCHE LTD
11. GLAXOSMITHKLINE PLC
12. JANSSEN PHARMACEUTICALS, INC.
13. MEDTRONIC
14. MERCK & CO., INC.
15. MYLAN N.V.
16. NOVARTIS INTERNATIONAL AG
17. PFIZER, INC.
18. RANDOX LABORATORIES LTD.
19. RESPONSE BIOMEDICAL CORPORATION
20. SANOFI S.A.
21. SIEMENS HEALTHCARE
22. THERMO FISHER SCIENTIFIC INC.
23. VERICEL CORPORATION
For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3271373-global-congenital-heart-disease-market-research-and-forecast-2018-2023
Some points from table of content:
CHAPTER 1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHT & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATIONS
2.3.1.1. UNITED STATES
2.3.1.2. EUROPEAN UNION
2.3.1.3. CHINA
2.3.1.4. INDIA
CHAPTER 3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. RISING PREVALENCE OF CONGENITAL HEART DISEASE
3.1.2. RISE IN ADOPTION OF MINIMALLY INVASIVE PROCEDURES
3.1.3. LARGE NUMBER OF DOMINATING MARKET PLAYERS
3.1.4. GROWING DEMAND FOR CATHETERIZATION
3.1.5. APPLICATION OF CARDIAC BIOMARKERS
3.2. RESTRAINTS
3.2.1. EXPENSIVE PROCEDURE
3.2.2. STRINGENT GOVERNMENT REGULATIONS
3.3. OPPORTUNITIES
3.3.1. ADVANCES AND RESEARCH IN CONGENITAL HEART DISEASE
3.3.2. SIGNIFICANT RESEARCH FUNDING FOR VARIOUS PROJECTS
CHAPTER 4. MARKET SEGMENTATION
4.1. GLOBAL CONGENITAL HEART DISEASE MARKET BY DEFECT TYPE
4.1.1. HEART VALVE DEFECTS
4.1.2. HEART WALL DEFECTS
4.1.3. BLOOD VESSEL DEFECTS
4.2. GLOBAL CONGENITAL HEART DISEASE MARKET BY DIAGNOSIS
4.2.1. ECHOCARDIOGRAM
4.2.2. CHEST X-RAY
4.2.3. MRI SCAN
4.2.4. OTHER
4.3. GLOBAL CONGENITAL HEART DISEASE MARKET BY TREATMENT
4.3.1. MEDICATIONS
4.3.2. IMPLANTABLE HEART DEVICES
4.3.3. CATHETER PROCEDURES
4.3.4. OPEN-HEART SURGERY
4.3.5. HEART TRANSPLANT
4.4. GLOBAL CONGENITAL HEART DISEASE MARKET BY END USER
4.4.1. HOSPITALS AND CLINICS
4.4.2. DIAGNOSTIC CENTRES
4.4.3. OTHER
CHAPTER 5. COMPETITIVE LANDSCAPE
5.1.1. KEY COMPANY ANALYSIS
5.1.2. KEY STRATEGIC ANALYSIS
CHAPTER 6. REGIONAL ANALYSIS
6.1. NORTH AMERICAN
6.1.1. UNITED STATES
6.1.2. CANADA
6.2. EUROPE
6.2.1. U.K
6.2.2. GERMANY
6.2.3. ITALY
6.2.4. SPAIN
6.2.5. FRANCE
6.2.6. ROE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.3.4. ROAPAC
6.4. REST OF THE WORLD
CHAPTER 7. COMPANY PROFILES
7.1. ABBOTT DIAGNOSTICS
Continued…….
For more information or any query mail at [email protected]
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym
Posted by
Vivian Dsena
on Monday July 09 2018, 5:50 AM EST.
All trademarks acknowledged.
Filed under Uncategorized.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
